2-(3,4-Dimethoxyphenyl)-8-methylquinoline-4-carboxylic acid

Catalog No. :
ACXYRI503
CAS No. :
438225-88-8
Molecular Formula :
C19H17NO4
Molecular Weight :
323.35

IUPAC Name:2-(3,4-dimethoxyphenyl)-8-methylquinoline-4-carboxylic acid

2-(3,4-Dimethoxyphenyl)-8-methylquinoline-4-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$175.00Login to see priceInquiryInquiry
1g95%$409.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3,4-Dimethoxyphenyl)-8-methylquinoline-4-carboxylic acid
IUPAC Name2-(3,4-dimethoxyphenyl)-8-methylquinoline-4-carboxylic acid
MDL No.MFCD03074946
Molecular FormulaC19H17NO4
Molecular Weight323.35
SMILESO=C(C1=CC(C2=CC=C(OC)C(OC)=C2)=NC3=C(C)C=CC=C13)O
InChI KeyNRLPAVYSIQVPHK-UHFFFAOYSA-N
Synonym2-(3,4-DIMETHOXYPHENYL)-8-METHYLQUINOLINE-4-CARBOXYLIC ACID;2-(3,4-dimethoxyphenyl)-8-methyl-4-quinolinecarboxylic acid;2-(3,4-dimethoxyphenyl)-8-methyl-cinchoninic acid;IVK/1019179;Oprea1_349393;4-Quinolinecarboxylic acid, 2-(3,4-dimethoxyphenyl)-8-methyl-
CAS No.438225-88-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACXYRI503 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXYRI503 route product structure diagram
    ACXYRI503438225-88-8
Inquiry

2. ACXYRI503 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLTFR361 route compound structure diagram
    ACLTFR361122775-35-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXYRI503 route product structure diagram
    ACXYRI503438225-88-8
Inquiry

Comments (0)